Immunosuppressive management following intestinal transplantation in adult patients

Transplant Proc. 2003 Sep;35(6):2075-7. doi: 10.1016/s0041-1345(03)00682-1.
No abstract available

MeSH terms

  • Adult
  • Biopsy
  • Employment
  • Factor XIII / therapeutic use
  • Graft Rejection / epidemiology
  • Graft Survival / physiology
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Immunosuppressive Agents / therapeutic use*
  • Infections / epidemiology
  • Intestinal Mucosa / pathology
  • Intestine, Small / transplantation*
  • Middle Aged
  • Muromonab-CD3 / therapeutic use
  • Patient Selection
  • Postoperative Complications / epidemiology
  • Quality of Life
  • Short Bowel Syndrome / surgery
  • Tissue Donors
  • Transplantation, Homologous / immunology*

Substances

  • Immunoglobulins, Intravenous
  • Immunosuppressive Agents
  • Muromonab-CD3
  • Factor XIII